Monday, July 17
15:00 | Arrival & Registration |
17:00 | Ice Breaker – Join us on the front lawn for falconry and archery |
18:30 | Drinks Reception |
19:00 |
Welcome & Participant Self-Introductions:
Fireside Chat: The Purposeful CEO—A seasoned advisor’s view on an industry in continual transformation and the CEOs that are leading the transformation
Networking Dinner Reception |
22:00 | Conclusion of Opening Events |
Tuesday, July 18
07:15 | Breakfast |
08:15 |
Overview and Rules of Engagement
Introduction of CEO Self-Assessment & Flash Surveys |
08:30 |
DISCUSSION 1: Setting the Strategic Direction—Are the Best Opportunities Aligned to Your “Reason for Being”?
|
09:45 | Morning Break |
10:15 |
DISCUSSION 2: Strategic Direction and The Board – When and how do you engage them in strategic discussions?
|
11:15 |
DISCUSSION 3: Planning for approval and commercialization early in the development process—Which steps are necessary and which are a waste of time and money?
|
12:15 | Networking Lunch at Sika |
13:15 |
DISCUSSION 4: Maximizing returns—How do you balance your shareholders’ needs, patient access, perception of your company, and perception in the industry?
|
14:15 |
DISCUSSION 5: Money—Which of the different flavors of capital for public and private companies is best for you? (Break out into two groups)
|
15:15 | Afternoon Break |
15:30 |
An unguarded conversation among CEOs and friends—Barriers to building a thriving European biotech community – are times changing?
|
16:30 | BIOTECH CEO SUMMIT GAMES |
18:30 | GALA DINNER AND AWARDS |
Wednesday, July 19
07:00 | Breakfast |
08:00 |
DISCUSSION 6: Communications strategy—What is the right story for your company and how do you set the stage to deal with adversity?
|
09:00 |
DISCUSSION 7: Dancing with bears —What makes for a successful alliance between “big” pharma and “small” biotech, and what makes them fail?
|
10:00 | Morning Break |
10:30 |
DISCUSSION 8: Team development—Does the company’s early team have the diversity of backgrounds and perspectives for later success?
|
11:30 |
DISCUSSION 9: Board development—How do you prod your board toward adapting to new realities and get them in alignment with your vision?
|
12:30 | Networking Lunch at Sika |
13:30 |
An unguarded conversation among CEOs and friends—The characteristics of a successful biotech CEO
|
14:30 |
DISCUSSION 10: Critical inflection points – How have you survived the make or break moments that led to success?
|
15:30 | CLOSING RECEPTION |